International Journal of Homoeopathic Sciences

Background: Perennial Allergic Rhinitis (PAR) is a chronic IgE-mediated inflammatory condition characterized by persistent nasal symptoms that significantly impair quality of life [1-3]. While antihistamines and corticosteroids remain primary treatment options, symptom recurrence, tolerance, and long-term dependence necessitate exploration of safer alternatives. LM potencies introduced by Hahnemann in the 6^th edition offer gentle, repeatable dosing suitable for chronic allergic conditions ^[5]. This pilot study evaluates the impact of individualized homeopathic LM-potency medicines on RCAT scores in PAR patients.
Methods: Five patients diagnosed with perennial allergic rhinitis were enrolled in a prospective, single-arm observational study. Individualized homeopathic medicines in LM potency were prescribed daily for four weeks. RCAT scores were recorded pre- and post-treatment.
Results: All five participants demonstrated improvement in RCAT scores, with a mean increase of 5.6 points (range 1-12). No adverse effects or aggravations occurred, and patient compliance with LM dosing was excellent.
Conclusion: Individualized LM-potency homeopathic treatment appears to improve nasal symptoms, sleep, and overall functioning in PAR. The method is safe, well-tolerated, and feasible for larger controlled trials.